Innovative research sheds light on migraine mechanisms and potential therapies

FHS
July 5, 2024
2:19 am

New research describes for the first time how a spreading wave of disruption and the flow of fluid in the brain triggers headaches, detailing the connection between the neurological symptoms associated with aura and the migraine that follows.

Teva fined $503 million for disparaging a rival and using patents to thwart competition

Teva Pharmaceutical, the world’s largest generic drugmaker, was fined $503 million by European antitrust regulators for delaying competition to a blockbuster multiple sclerosis medicine. The European

October 31, 2024

AHA 2024: Plozasiran demonstrates promising Phase III results in FCS adults – Pharmaceutical Technology

On November 16, during the American Heart Association (AHA) 2024 Annual Scientific Sessions in Chicago, IL, US, findings from the Phase III PALISADE (NCT05089084) clinical

November 18, 2024

Revolutionizing microscopy with affordable high-resolution techniques

Researchers at the University of Illinois at Urbana-Champaign have shown for the first time that expensive aberration-corrected microscopes are no longer required to achieve record-breaking

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.